Delivery Order SPE2DB25D7068-SPE2DB25FTWTX

Award Date 5/20/25
Potential Completion Date 5/21/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,426.01 firm fixed price delivery order is for the supply of GATIFLOXACIN 0.5% EYE DROPS 2.5ML. The contract has an ultimate completion date of August 26, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026,...
This federal contract award is for the delivery of GATIFLOXACIN 0.5% EYE DROPS 2.5ML to the Defense Logistics Agency (DLA). The $1,722.90 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 9, 2024, with a completion date of July 10, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,123.89 firm fixed price delivery order is for the supply of Gatifloxacin 0.5% eye drops in 2.5 ml containers. The contract has no set-aside designation and is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. This...
This federal contract award, with ID SPE2DB20D7059|SPE2DB25FQDZ5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is a Delivery Order with a Firm Fixed Price pricing type, is for the supply of OFLOXACIN 0.3% EYE DROPS 5ML. The contract has a ceiling value of $1,019.31 and an ultimate completion date of April 14, 2025. AmerisourceBergen Drug Corp is the prime contractor,...
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Ofloxacin 0.3% eye drops to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,086.42 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA, running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of OFLOXACIN 0.3% EAR DROPS 5ML. The $5,469.25 firm fixed-price delivery order has an ultimate completion date of January 17, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products...
This federal contract award, valued at $1,507.22, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of a 0.5% eye drop lubricant product, with a period of performance through November 15, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award is for medical supplies and pharmaceuticals, including a variety of eye drops, provided by prime contractor Amerisourcebergen Drug Corp to the Defense Logistics Agency (DLA). The contract has a total ceiling value of $6,805.05 and an ultimate completion date of January 16, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order with a Firm Fixed Price of $1,796.37 for the supply of OFLOXACIN 0.3% EAR DROPS 5ML. The contract is awarded by the Medical Supply Chain, which is an alternate name for the Defense Logistics Agency (DLA), a civilian agency. The contract has an ultimate completion date of May 16, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions...
This federal contract award is a delivery order worth $5,867.34 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MIEBO 100% EYE DROP 3ML medical products, with a period of performance through November 7, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which...
  • SPE2DB25D7068
    Indefinite Delivery Contract
  • SPE2DB25D7068-SPE2DB25FTWTX
    Delivery Order

This federal contract award is for $1,508.28 and was granted to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of GATIFLOXACIN 0.5% EYE DROPS 2.5ML, a pharmaceutical product, with a completion date of May 21, 2025. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and there was no set-aside designation used. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 8/24/25, 12:57 AM